{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:54:42Z","timestamp":1788382482138,"version":"build-2803163510"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. Our previous studies have found that Shuangyu Tiaozhi Decoction (SYTZD) could produce an improvement in NAFLD-related indicators, but the underlying mechanism associated with this improvement remains unclear. The study aimed to investigate the potential mechanism of SYTZD against NAFLD through network pharmacology and experimental verification. The components of SYTZD and SYTZD drug containing serum were analyzed using ultra-performance liquid chromatography to quadrupole\/time-of-flight mass spectrometry (UPLC-Q\/TOF-MS). Active components and targets of SYTZD were screened by the traditional Chinese medical systems pharmacology (TCMSP) and encyclopedia of traditional Chinese medicine (ETCM) databases. NAFLD-related targets were collected from the GeneCards and DisGeNET databases. The component-disease targets were mapped to identify the common targets of SYTZD against NAFLD. Protein\u2013protein interaction (PPI) network of the common targets was constructed for selecting the core targets. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the core targets was performed using the database for annotation, visualization, and integrated discovery (DAVID) database. Furthermore, animal and cell models were constructed for validating the predictions of network pharmacology. Lipid accumulation, liver histopathology, insulin resistance, and core gene expression were measured by oil red O staining, hematoxylin and eosin staining, insulin tolerance test, real-time quantitative polymerase chain reaction, and Western blotting, respectively. Two components and 22 targets of SYTZD against NAFLD were identified by UPLC-Q\/TOF-MS and relevant databases. PPI analysis found that ESR1, FASN, mTOR, HIF-1\u03b1, VEGFA, and GSK-3\u03b2 might be the core targets of SYTZD against NAFLD, which were mainly enriched in the thyroid hormone pathway, insulin resistance pathway, HIF-1 pathway, mTOR pathway, and AMPK pathway. Experimental results revealed that SYTZD might exert multiple anti-NAFLD mechanisms, including improvements in lipid deposition, inflammation, and insulin resistance. SYTZD treatment led to decreases in the lipid profiles, hepatic enzyme levels, inflammatory cytokines, and homeostatic model assessment for insulin resistance (HOMA-IR). SYTZD treatment affected relative mRNA and protein levels associated with various pathways. Our findings reveal that SYTZD could alleviate NAFLD through a multi-component, multi-target, and multi-pathway mechanism of action.<\/jats:p>","DOI":"10.3389\/fphar.2022.1016745","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T06:50:25Z","timestamp":1669186225000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo"],"prefix":"10.3389","volume":"13","author":[{"given":"Guoliang","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.neuint.2020.104707","article-title":"Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer\u2019s disease","volume":"135","author":"Akhtar","year":"2020","journal-title":"Neurochem. Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41596-019-0256-1","article-title":"A toolbox for the longitudinal assessment of healthspan in aging mice","volume":"15","author":"Bellantuono","year":"2020","journal-title":"Nat. Protoc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"10345","DOI":"10.1080\/21655979.2021.1996317","article-title":"Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency","volume":"12","author":"Cao","year":"2021","journal-title":"Bioengineered"},{"key":"B5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-nutr-071714-034355","article-title":"The roles of mTOR complexes in lipid metabolism","volume":"35","author":"Caron","year":"2015","journal-title":"Annu. Rev. Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: The state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese medicine in nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"109976","DOI":"10.1016\/j.biopha.2020.109976","article-title":"Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine","volume":"127","author":"Dang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1080\/14786419.2021.2004598","article-title":"Zanzibar yam (Dioscorea sansibarensis Pax) isolates exhibit cyclooxygenase enzyme and lipid peroxidation inhibitory activities","author":"Dissanayake","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.actbio.2018.11.033","article-title":"Characterization of a tissue-engineered choroid","volume":"84","author":"Djigo","year":"2019","journal-title":"Acta Biomater."},{"key":"B12","doi-asserted-by":"publisher","first-page":"8872702","DOI":"10.1155\/2021\/8872702","article-title":"Phloroglucinol strengthens the antioxidant barrier and reduces oxidative\/nitrosative stress in nonalcoholic fatty liver disease (NAFLD)","volume":"2021","author":"Drygalski","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model","volume":"24","author":"Fang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5114\/ceh.2019.83152","article-title":"Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children","volume":"5","author":"Flisiak-Jackiewicz","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"E3863","DOI":"10.3390\/ijms21113863","article-title":"The role of insulin resistance and diabetes in nonalcoholic fatty liver disease","volume":"21","author":"Fujii","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"147655","DOI":"10.14814\/phy2.14765","article-title":"Rosiglitazone promotes glucose metabolism of GIFT tilapia based on the PI3K\/Akt signaling pathway","volume":"9","author":"Guan","year":"2021","journal-title":"Physiol. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.01185","article-title":"Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula Zuojin Pill in suppressing hepatocellular carcinoma","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms","volume":"225","author":"Huang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"D1117","DOI":"10.1093\/nar\/gkx1028","article-title":"Tcmid 2.0: A comprehensive resource for TCM","volume":"46","author":"Huang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","article-title":"Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity","volume":"177","author":"Ioannou","year":"2019","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.6026\/97320630016893","article-title":"Molecular docking analysis of compounds from Justica adhatoda L with glycogen synthase kinase-3 \u03b2","volume":"16","author":"Jayaraman","year":"2020","journal-title":"Bioinformation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2022.2050362","article-title":"Contribution of maternal mosaicism to false-positive chromosome X loss associated with noninvasive prenatal testing","volume":"288","author":"jing","year":"2022","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.dib.2018.12.089","article-title":"Liver transcriptome data of Esr1 knockout male rats reveals altered expression of genes involved in carbohydrate and lipid metabolism","volume":"22","author":"Khristi","year":"2019","journal-title":"Data Brief."},{"key":"B27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mce.2019.04.005","article-title":"Disruption of ESR1 alters the expression of genes regulating hepatic lipid and carbohydrate metabolism in male rats","volume":"490","author":"Khristi","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.3390\/ijms221910701","article-title":"Chronic and cycling hypoxia: Drivers of cancer chronic inflammation through hif-1 and nf-\u03bab activation. A review of the molecular mechanisms","volume":"22","author":"Korbecki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/hep.31568","article-title":"Activating adenosine monophosphate\u2013activated protein kinase mediates fibroblast growth factor 1 protection from nonalcoholic fatty liver disease in mice","volume":"73","author":"Lin","year":"2021","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fphar.2020.01036","article-title":"Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K\/AKT\/NF-\u03baB oxidative and inflammatory signaling and gut microbiota","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"668418","DOI":"10.3389\/fphar.2021.668418","article-title":"Constituents, pharmacokinetics, and pharmacology of gegen-qinlian decoction","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"BSR20204216","DOI":"10.1042\/BSR20204216","article-title":"Gualou xiebai banxia decoction ameliorates poloxamer 407-induced hyperlipidemia","volume":"41","author":"Luo","year":"2021","journal-title":"Biosci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11655-019-3064-0","article-title":"Network pharmacology in research of Chinese medicine formula: Methodology, application and prospective","volume":"26","author":"Luoting","year":"2020","journal-title":"Chin. J. Integr. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"E1948","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: An overview","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jhep.2021.04.050","article-title":"Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy","volume":"75","author":"McConnell","year":"2021","journal-title":"J. Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1165\/rcmb.2020-0492OC","article-title":"Hepatocyte HIF-1 and intermittent hypoxia independently impact liver fibrosis in murine nonalcoholic fatty liver disease","volume":"65","author":"Mesarwi","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and its management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutr. Clin. Pract."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1016\/j.molcel.2021.06.003","article-title":"SREBP-1c impairs ULK1 sulfhydration-mediated autophagic flux to promote hepatic steatosis in high-fat-diet-fed mice","volume":"81","author":"Nguyen","year":"2021","journal-title":"Mol. Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","article-title":"TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation","volume":"17","author":"Park","year":"2021","journal-title":"Autophagy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism."},{"key":"B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: A review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.31209","article-title":"Decreased hepatocyte autophagy leads to synergistic IL-1\u03b2 and TNF mouse liver injury and inflammation","volume":"72","author":"Shen","year":"2020","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4805926","DOI":"10.1155\/2019\/4805926","article-title":"Shuangyu tiaozhi granule attenuates hypercholesterolemia through the reduction of cholesterol synthesis in rat fed a high cholesterol diet","volume":"2019","author":"Shi","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/10408363.2019.1711360","article-title":"Fructose and hepatic insulin resistance","volume":"57","author":"Softic","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2548154","DOI":"10.1155\/2018\/2548154","article-title":"Hypoxic signaling and cholesterol lipotoxicity in fatty liver disease progression","volume":"2018","author":"Tirosh","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1080\/21655979.2022.2026862","article-title":"Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"B53","doi-asserted-by":"publisher","first-page":"214588","DOI":"10.1096\/fj.202000763RRR","article-title":"Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice","volume":"35","author":"Wang","year":"2021","journal-title":"FASEB J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"ITC65","DOI":"10.7326\/AITC201811060","article-title":"Nonalcoholic fatty liver disease","volume":"169","author":"Wang","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-15-0602-4_3","article-title":"Regulation of autophagy by mTOR signaling pathway","volume":"1206","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"682862","DOI":"10.3389\/fchem.2021.682862","article-title":"Using network pharmacology and molecular docking to explore the mechanism of Shan ci gu (cremastra appendiculata) against non-small cell lung cancer","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Chem."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ - linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"B59","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1042\/BCJ20190468","article-title":"Adipocyte lipolysis: From molecular mechanisms of regulation to disease and therapeutics","volume":"477","author":"Yang","year":"2020","journal-title":"Biochem. J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and nash in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10030511","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: The fmt-trim double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PLoS Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"23193","DOI":"10.18632\/aging.203611","article-title":"Network pharmacology for systematic understanding of Schisandrin B reduces the epithelial cells injury of colitis through regulating pyroptosis by AMPK\/Nrf2\/NLRP3 inflammasome","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12876-020-01515-5","article-title":"HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbr.2017.11.015","article-title":"Diabetes mellitus and alzheimer\u2019s disease: GSK-3\u03b2 as a potential link","volume":"339","author":"Zhang","year":"2018","journal-title":"Behav. Brain Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00018-019-03263-6","article-title":"Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP\/PPAR\u03b3 pathways","volume":"77","author":"Zhao","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice","volume":"25","author":"Zhou","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.600175","article-title":"Liraglutide alleviates hepatic steatosis and liver injury in T2MD rats via a GLP-1R dependent AMPK pathway","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"854790","DOI":"10.3389\/fphar.2022.854790","article-title":"Diosgenin ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and related lipid\/amino acid metabolism in high fat diet-fed rats","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B70","first-page":"2020","article-title":"Applications of network pharmacology in traditional Chinese medicine research","author":"Zhou","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1875-5364(20)30017-0","article-title":"Fatty liver diseases, mechanisms, and potential therapeutic plant medicines","volume":"18","author":"Zhu","year":"2020","journal-title":"Chin. J. Nat. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1016745\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T06:50:28Z","timestamp":1669186228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1016745\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":71,"alternative-id":["10.3389\/fphar.2022.1016745"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1016745","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"article-number":"1016745"}}